In 2020 Uruguay was the country of the region with the highest growth in the incorporation of Freelite, an automated trial that allows the measurement of free light chains, and with it, early detection and with the highest possible diagnostic sensitivity of multiple myeloma.
We thank Binding Site recognition of our work, but in particular we celebrate the professionals with whom we work, who incorporate into their laboratories this superior technique to ensure the best results for their patients.
